Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-24 @ 10:36 PM
NCT ID:
NCT02077335
Eligibility Criteria:
Inclusion Criteria:
* Biopsy proven Adenocarcinoma of the Prostate
* Clinical stage T1c, T2a or T2b
* PSA less than 20 ng/ml
* Gleason Score 6 or 7
Exclusion Criteria:
* Age less than 18 years
* Clinical stage T2c, T3 ou T4
* Clinical Stage N1
* Clinical Stage M1
* Prostate Specific Antigen (PSA) more than 20 ng/ml
* Gleason score 8 or higher
* IPSS score 19 or higher with alpha-blockers
* Past radiation therapy to the pelvis
* History of Collagen Vascular Disease
* History of Inflammatory Bowel Disease
* Bilateral Hip Prosthesis
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02077335
Study Brief:
Protocol Section:
NCT02077335